Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Pancreatic Cancer American Joint Committee on Cancer v8”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableStudy completedNCT04449679
What this trial is testing

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+83 more
Thomas Jefferson University 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940286
What this trial is testing

Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic AdenocarcinomaStage IA Pancreatic Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 13
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Early research (Phase 1)Active Not RecruitingNCT03816358
What this trial is testing

Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 74
Early research (Phase 1)Looking for participantsNCT05687123
What this trial is testing

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Pancreatic Neuroendocrine TumorPancreatic NeoplasmStage III Pancreatic Neuroendocrine Tumor AJCC v8+2 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT03608631
What this trial is testing

IExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

Who this might be right for
KRAS NP_004976.2:p.G12DMetastatic Pancreatic AdenocarcinomaPancreatic Ductal Adenocarcinoma+1 more
M.D. Anderson Cancer Center 28
Early research (Phase 1)WithdrawnNCT06206876
What this trial is testing

FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal Adenocarcinoma+5 more
Roswell Park Cancer Institute
Not applicableLooking for participantsNCT07124611
What this trial is testing

A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer

Who this might be right for
Localized Pancreatic Ductal AdenocarcinomaStage 0 Pancreatic Cancer AJCC v8Stage I Pancreatic Cancer AJCC v8+1 more
Ohio State University Comprehensive Cancer Center 25
Not applicableLooking for participantsNCT06595160
What this trial is testing

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8
Emory University 87
Testing effectiveness (Phase 2)Looking for participantsNCT05518903
What this trial is testing

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

Who this might be right for
Localized Pancreatic AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage 0 Pancreatic Cancer AJCC v8+2 more
Mayo Clinic 130
Early research (Phase 1)Looking for participantsNCT04484909
What this trial is testing

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma+1 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT07214298
What this trial is testing

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Roswell Park Cancer Institute 35
Early research (Phase 1)Ended earlyNCT04809766
What this trial is testing

Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Fred Hutchinson Cancer Center 9
Early research (Phase 1)Study completedNCT03784677
What this trial is testing

A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRefractory Ovarian Carcinoma+20 more
M.D. Anderson Cancer Center 11
Early research (Phase 1)Active Not RecruitingNCT02595931
What this trial is testing

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Lung Small Cell CarcinomaMetastatic Malignant Solid Neoplasm+15 more
National Cancer Institute (NCI) 66
Early research (Phase 1)Active Not RecruitingNCT05055323
What this trial is testing

Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Ductal AdenocarcinomaStage 0 Pancreatic Cancer AJCC v8Stage I Pancreatic Cancer AJCC v8+5 more
Thomas Jefferson University 20
Early research (Phase 1)WithdrawnNCT03925428
What this trial is testing

Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmAnn Arbor Stage III B-Cell Non-Hodgkin Lymphoma+14 more
National Cancer Institute (NCI)
Not applicableEnded earlyNCT04400903
What this trial is testing

Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8Stage IA Pancreatic Cancer AJCC v8+1 more
OHSU Knight Cancer Institute 110
Early research (Phase 1)Looking for participantsNCT05685602
What this trial is testing

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT01585805
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 88
Load More Results